Although we did not detect any accumulation of TDP-43 in axons of PARK2 PD neurons, we showed that NMN chronic treatment significantly reduced pathological aggregation of TDP-43 in axons from TDP-43N390D ALS hMNs (Fig. 9A). This evidence concerns the gene PRKN and amyotrophic lateral sclerosis.